Any feedback?
Literature summary for 3.4.24.75 extracted from
- In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus (2017), Iran. J. Microbiol., 9, 208-212 .
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | the enzyme can be used in life-threatening infections, such as endocarditis to increase the early in vivo activity of the antibiotics, and to prevent the emergence of linezolid resistant mutants | Staphylococcus simulans |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Staphylococcus simulans | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| methicillin-resistant Staphylococcus aureus cells + H2O | the enzyme causes rapid lysis of Staphylococcus aureus cells | Staphylococcus simulans | ? | - |
? |  |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
